$ILMN

Meister Keith A. sold $735K of ILMN (indirect holdings)

Meister Keith A. sold 4,579 indirectly-held shares of ILLUMINA, INC. (ILMN) at $160.50 ($0.73M total) on 2026-05-29.

Original reporting
SEC EDGAR · Meister Keith A.
Published Jun 1, 2026, 10:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ILMN
Neutral
medium confidence
Mentioned
$ILMN
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ILMNNeutralLow
01

Why it matters

The disclosure updates the record of insider ownership and may slightly influence sentiment, but it does not introduce new company fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but this single sale is unlikely to drive a sustained repricing without accompanying company news.

03

What to watch

The filing notes indirect ownership and no 10b5-1 plan; without additional context (other transactions, total holdings trend), interpreting intent is uncertain.

Relevance 6/10Novelty 3/10Timing: Filed June 1; sale executed May 29 (after-market disclosure timing).

Background

SEC Form 4 insider transaction disclosure for Illumina director Keith A. Meister.

Company-level read

Ticker impact

$ILMNNeutralMedium confidence
Context

Illumina director Keith A. Meister sold 4,579 shares in an open-market transaction reported on SEC Form 4.

Expected impact

Likely limited near-term impact; any effect should be small and fade unless followed by additional selling or company-specific news.

Evidence & confidence

The filing is a disclosed insider sale (not a buy), but it lacks context like 10b5-1 plan details and does not indicate a company event (earnings, guidance, deal, litigation).

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide trigger.

None indicated.

None indicated.

Counterpoint

Insider sales can be routine for diversification or tax planning; absence of a stated 10b5-1 plan doesn’t automatically imply bearish conviction.

Key entities

  • Illumina, Inc.

    Subject of the SEC Form 4 insider sale; director sold shares at $160.50.

  • Keith A. Meister

    Director who executed the open-market sale of 4,579 shares.

Related articles

$ILMNHighAI 9/10

Illumina (ILMN) Q2 2026 Earnings Call Transcript

Illumina (ILMN) reported Q2 2026 revenue of $1.16B, up 9.5% YoY, and non-GAAP EPS of $1.31. Clinical consumables and NovaSeq X placements drove results. Gross margin was 68.2%. Full-year 2026 guidance was raised to $4.60B-$4.64B revenue and $5.30-$5.40 EPS. Cash was $1.17B vs $1.99B debt.

$ILMNHighAI 9/10

Illumina (ILMN) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Conor McNamara Chief Executive Officer - Jacob Thaysen Chief Financial Officer - Ankur Dhingra TAKEAWAYS Total Revenue -- $1.16 billion, representing a 9.5% increase year over year driven by clinical market demand and the NovaSeq X expansion. Rest of World Organic Revenue -- Increased 8.1% year over year, exceeding the high end of management's previous guidance.

$ILMNMedAI 8/10

Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full

Genomics company Illumina (NASDAQ: ILMN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.62 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.31 per share was 6.8% above analysts’ consensus estimates. Is now the time to buy Illumina? Find out by accessing our full research report, it’s free.

$ILMNHigh

ILLUMINA, INC. (ILMN): Results of Operations and Financial Condition

ILLUMINA, INC. (ILMN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q226earningsrelease.htm EX-99.1 Document Investors: Conor McNamara +1.858.291.6421 ir@illumina.com Media: Christine Douglass pr@illumina.com Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026 San Diego, July 30, 2026 /PRNewswire/ -- Illumina, Inc.